Methods for the diagnostic of an autoimmune disease
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Institut Curie, Universite Paris Descartes, Centre National de la Recherche Scientifique (CNRS)
InventorsEliane PIAGGIO, Louis PEROL
Life of this patent
Estimating the term…
Abstract
An in vitro method for determining whether a patient has, or is at risk of having or developing an autoimmune disease or for assessing the severity or predicting the outcome of an autoimmune disease, comprising a step of detecting or quantifying in a biological sample obtained from said patient an immune anti-IL2 response, peptides specifically recognised by anti-1L2 antibodies or IL-2-specific T cells of T1D, systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome and autoimmune polymyositis patients, and pharmaceutical compositions.
Claims10
1-15. (canceled)
An in vitro method for determining whether a patient has, or is at risk, of having or developing an autoimmune disease or for assessing the severity or predicting the outcome of an autoimmune disease, wherein said in vitro method comprises a step of detecting or quantifying, in a biological sample obtained from said patient, an immune anti-IL-2 response.
Dependencies are inferred from the claim text.